On the other hand, to determine whether this polymorphism is associated with soluble levels in women with BC, we compared the soluble levels of MIF and TNFα in women with BC according to ‐173G > C MIF. Nevertheless, significant differences were not observed, as well as by applying the dominant model. The gene discussed is TNF; the disease is breast cancer.